基因组不稳定过程中的空间和时间多样性定义了肺癌的演变
Elza C de Bruin1, Nicholas McGranahan2, Richard Mitter3
1Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6BT, UK.
概括
对非小细胞肺癌 (NSCLC) 的基因组分析揭示了分支进化和显著的内异质性. 这些复杂的基因组变化,包括驱动突变和不稳定性,有助于应对NSCLC的挑战.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 癌症 演化 演化 癌症 演化
背景情况:
- 非小细胞肺癌 (NSCLC) 的预后很差,部分原因是复杂的基因组变化.
- 了解NSCLC的空间和时间基因组变化对于改善治疗结果至关重要.
研究的目的:
- 剖析人类NSCLC的空间和时间基因组进化.
- 确定NSCLC异质性的基因组基础及其对预后的影响.
主要方法:
- 从七个可操作的NSCLC瘤中测序了25个空间上不同的区域.
- 对副本数量变化,转位和突变的分析,包括与APOBEC相关的活动.
- 对目前和前吸烟者的瘤突变模式的比较分析.
主要成果:
- 证据表明NSCLC的分支进化模式,驱动突变出现在不同的阶段.
- 在基因组变化中表现出明显的内异质性,包括副本数量变化和转位.
- 随着时间的推移,吸烟者的突变特征发生变化,吸烟相关突变减少,APOBEC相关突变增加.
- 在前吸烟者中识别了基因组复制事件,这些事件在亚克隆多样化之前发生,这表明了长时间的潜伏期.
结论:
- 在NSCLC中区域不同的驱动突变和普遍的基因组不稳定性使治疗策略复杂化.
- NSCLC演变的异质和动态性质对治疗成功提出了重大挑战.
- 了解这些进化动态是开发更有效的NSCLC治疗方法的关键.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
12.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.2K
Cancers Originate from Somatic Mutations in a Single Cell
3.0K
3.0K
Adaptive Mechanisms in Cancer Cells
5.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
Tumor Progression
6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
Cancer Prevention
6.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.5K
Spontaneous and Induced Mutations
2.8K
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
2.8K


